SalfaCorp Stock

SalfaCorp Forward P/E

The Forward P/E Ratio of SalfaCorp (SALFACORP.SN) as of Sep 7, 2026 is 14.19. In the previous year, Forward P/E Ratio was 16.69 — a change of -14.98% (lower).

Forward P/E

14.19

YoY

-14.98%

Last updated:

Forward P/E Ratio of SalfaCorp is 2026 14.19 . Forward P/E Ratio of SalfaCorp was 2025 16.69 . It decreases by -14.98% lower compared to the previous year.

The SalfaCorp Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
28.32 CLP
Jan 1, 2019
30.91 CLP
Jan 1, 2020
52.25 CLP
Jan 1, 2021
23.31 CLP
Jan 1, 2022
20.16 CLP
Jan 1, 2023
16.76 CLP
Jan 1, 2024
16.69 CLP
Jan 1, 2025
14.19 CLP
The SalfaCorp Forward P/E history
YEARForward P/EYoY
14.19-14.98%
16.69-0.37%
16.76-16.88%
20.16-13.53%
23.31-55.39%
52.25+69.07%
30.91+9.14%
28.32-2.53%
29.05+1.78%
28.55-9.34%
31.49-2.25%
32.21
Access this data via the Eulerpool API

SalfaCorp Stock analysis

What does SalfaCorp do? SalfaCorp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SalfaCorp stock

Forward P/E Ratio of SalfaCorp is 14.19 in 2026.

Forward P/E Ratio of SalfaCorp changed from 16.69 to 14.19, representing a -14.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio SalfaCorp since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's SalfaCorp with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — SalfaCorp

All Key Metrics — SalfaCorp